MyoKardia
Latest round
- Series B
Last raised
- Apr 2015
Total raised
- $94M
Investors
- 7
About MyoKardia
Established in 2012 and based in California, US, MyoKardia, Inc. operates as a biopharmaceutical company that focuses on the research and development of therapies for the treatment of cardiomyopathy disease and other heart failure-related diseases.
Who invested in MyoKardia
7 investors across 3 rounds
See all investors in MyoKardia
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about MyoKardia
Who invested in MyoKardia?
MyoKardia has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MyoKardia raised?
MyoKardia has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did MyoKardia last raise money?
MyoKardia's most recent round on record is a Series B, in Apr 2015.
What does MyoKardia do?
Established in 2012 and based in California, US, MyoKardia, Inc.
Where is MyoKardia headquartered?
MyoKardia is headquartered in Brisbane, US.
Which VCs invest in companies like MyoKardia?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at MyoKardia's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like MyoKardia? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.